Efficacy of Highly Selective COX-2 Inhibitors in Preemptive Analgesia for Third Molar Surgery: A Meta-analysis

Key Points

• This research aims to evaluate the efficacy of the COX-2 inhibitor etoricoxib for preemptive analgesia in third molar surgery.
• Conducted a meta-analysis of existing studies on etoricoxib and analgesia post third molar extraction.
• Analyzed pain levels and functional recovery in patients receiving etoricoxib preemptively.
• Compared outcomes between patients using etoricoxib and those who did not.
• Etoricoxib significantly reduced postoperative pain compared to control treatments.
• Patients receiving etoricoxib reported better functional recovery after surgery.

Abstract